Recent News

• 04.07.2025 - Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
• 03.13.2025 - Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
• 03.03.2025 - Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results
• 03.03.2025 - Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
• 02.13.2025 - Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
• 02.07.2025 - Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

Recent Filings

• 03.13.2025 - 8-A12B Registration of securities [Section 12(b)]
• 03.13.2025 - EX-99.1 EX-99.1
• 03.13.2025 - 8-K Current report
• 03.10.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 03.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.03.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.03.2025 - EX-99.1 EX-99.1
• 03.03.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.03.2025 - 8-K Current report
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors